ALEXANDRIA, Va., July 23 -- United States Patent no. 12,364,751, issued on July 22, was assigned to Gilead Sciences Inc. (Foster City, Calif.).

"HBV vaccines and methods treating HBV" was invented by Scott J. Balsitis (Moss Beach, Calif.), Sarah M. Ahmadi-Erber (Vienna), Timo Schippers (Vienna) and Sarah Schmidt (Vienna).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are HBV immunogenic polypeptides, polynucleotides encoding such polypeptides, vectors expressing such immunogenic polypeptides for use in eliciting an immune response against HBV; pharmaceutical and immunogenic compositions and kits comprising such polypeptides, polynucleotides or vectors, and methods of use in treating and/or preventing...